NCT03577626 A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers Status UNKNOWN Phase PHASE1
NCT03570346 Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects Status UNKNOWN Phase PHASE1
NCT03556202 A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) Status TERMINATED Phase PHASE3
NCT03542994 A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03540160 Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) Status TERMINATED Phase PHASE3
NCT03539419 Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain Status COMPLETED Phase N/A
NCT03535194 A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) Status COMPLETED Phase PHASE3
NCT03518047 Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation Status COMPLETED Phase PHASE3
NCT03511755 12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN Status COMPLETED Phase NA
NCT03506477 Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color Status COMPLETED Phase PHASE4
NCT03493269 A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis Status COMPLETED Phase PHASE1
NCT03485560 Revitalization of Damaged Skin Due to Chronic Skin Diseases Status UNKNOWN Phase EARLY_PHASE1
NCT03483311 Resolvin D1 in Psoriasis Before and After Narrowband UVB Phototherapy Status UNKNOWN Phase NA
NCT03482011 A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03478787 Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03478280 Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis Status UNKNOWN Phase PHASE4
NCT03475914 Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis Status COMPLETED Phase N/A